|
|
Article: Study results from C. Trenkwalder and colleagues update understanding of restless legs syndrome therapy.
- Article from:
- Biotech Week
- Article date:
- July 30, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Researchers detail in 'Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial,' new data in restless legs syndrome. "Continuous administration of a dopamine agonist could be used to treat patients with restless legs syndrome. Our aim was to investigate the efficacy of transdermal rotigotine in the treatment of idiopathic restless legs syndrome," researchers in Kassel, Germany report (see also Restless Legs Syndrome Therapy).
"In this randomised, double-blind, placebo-controlled trial, 458 patients with moderate-to-severe idiopathic restless legs syndrome (average baseline ...